[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100550625":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":12,"centralContacts":12,"locations":12,"responsibleParty":27,"collaborators":12,"id":31,"slug":32,"hasResults":33,"nctId":34,"briefTitle":35,"officialTitle":36,"acronym":12,"eligibilityCriteria":37,"healthyVolunteers":33,"sex":38,"minAge":39,"maxAge":40,"enrollmentInfo":41,"targetDuration":12,"studyType":44,"phases":45,"briefSummary":48,"conditions":49,"keywords":12,"overallStatus":51,"whyStopped":12,"lastUpdateSubmitDate":52,"lastUpdatePostDateStruct":53,"startDateStruct":56,"completionDateStruct":58,"leadSponsor":60,"locationsCount":12},{"fullName":5,"class":6},"Tanta University","OTHER",[8,13],{"label":9,"type":10,"description":11,"interventionNames":12},"control","NO_INTERVENTION","no intervention",null,{"label":14,"type":15,"description":16,"interventionNames":17},"probiotics","ACTIVE_COMPARATOR","will receive 5 drops of probiotic supplement containing Bacillus clausil spores (Enterogermania amp 2 billion\u002F5 mL) once daily plus phototherapy till discharge.",[18],"Drug: Probiotic Formula",[20],{"type":21,"name":22,"description":23,"armGroupLabels":24,"otherNames":25},"DRUG","Probiotic Formula","drops of probiotic supplement containing bacillus clausil spores (Enterogermania Amp 2 Billion\u002F5Ml )",[14],[26],"lactobacillus",{"type":28,"investigatorFullName":29,"investigatorTitle":30,"investigatorAffiliation":5,"oldNameTitle":12,"oldOrganization":12},"PRINCIPAL_INVESTIGATOR","Samah Safwat","Principal investigator","100550625","phase-1-the-effectiveness-of-probiotics-in-neonatal-jaundice-100550625",false,"NCT06449508","The Effectiveness of Probiotics in Neonatal Jaundice","Role of Probiotics Administered as an Adjuvant Therapy in Pathological Neonatal Unconjugated Hyperbilirubinemia","Inclusion Criteria:\n\n* Neonate suffered from pathological unconjugated hyper-bilirubinemia with Total serum bilirubin (TSB) between 5-15mg\u002Fdl and need phototherapy.\n\nExclusion Criteria:\n\n* neonates who have kernicterus.\n* neonates who have ventilation problem.\n* neonates who have heart failure.\n* -neonates who have asphyxia.\n* neonates who have history of Rh incompatibility","ALL","1 Day","30 Days",{"count":42,"type":43},44,"ESTIMATED","INTERVENTIONAL",[46,47],"PHASE1","PHASE2","Hyperbilirubinemia is a prevalent problem in babies that necessitates medical attention. Probiotic administration as adjuvant therapy may have a positive impact on the pathological neonatal unconjugated hyperbilirubinemia.",[50],"Jaundice, Neonatal","NOT_YET_RECRUITING","2024-06-07",{"date":54,"type":55},"2024-06-10","ACTUAL",{"date":57,"type":43},"2024-07-01",{"date":59,"type":43},"2025-07-01",{"name":5,"class":6}]